In the latest powerpoint presentation on what is in/out of scope for the CCDD, investigational agents are considered as out of scope. I agree that agents tested in phase 1 clinical trials for now can be considered out of scope. At a certain stage an investigational agent might already have a DIN assigned. If so do we still want this agent to be "out of scope" ?
Improving the quality of patient care through the effective sharing of clinical information among health care organizations, clinicians and their patients.
Print
Email
CCDD and scope for Investigational Agents (Medications)
Twitter